Tuesday, November 29, 2016

Actelion shares plunge on report it eyes "complicated" J&J deal

ZURICH, Nov 29 (Reuters) - Shares in Swiss biotech company

Actelion plunged on Tuesday after a report the company

was not actively considering selling itself, but instead

weighing a "complicated...

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)